Healthy Soil, Coming to a Theater Near You: 5 Lessons From 'The Biggest Little Farm'
By Karen Perry Stillerman
An email in my inbox last month caught my attention. It was from author, environmental advocate, and Academy Award-winning film producer Laurie David (An Inconvenient Truth), and it offered a preview of The Biggest Little Farm, a new documentary film David had coming out soon. "I promise you that any person that goes to see this film will leave inspired and caring a whole lot more for the planet," her note said. "I promise you it will help your organization achieve your goals!"
I clicked on the link, watched the trailer, was intrigued. The movie looked gorgeous. But would it hold up to scrutiny from skeptical agricultural scientists?
A few days later, in a conference room with several members of the Union of Concerned Scientists (UCS) food and agriculture team, I dimmed the lights and let the film roll. The Biggest Little Farm (in theaters this month) chronicles the adventures of filmmaker John Chester and his wife Molly as they leave their lives in Los Angeles behind to start a diversified farm on an exhausted piece of land north of the city, where they intend to live and grow food "in perfect harmony with nature."
At first, the storytelling seems to veer toward the precious. John documents the promise they made to their rescue pup Todd about how much he'd love being a farm dog. The narration, over cute animation, extols the idyllic life John and Molly imagine for themselves. But I soon realized he was setting up viewers for the same jolt he and Molly would soon get — repeatedly — about the harsh realities of farming, especially when you're trying something new and complex.
Because it turns out this kind of farming isn't all rainbows and puppies and adorable baby goats. It's also exhausting and sometimes heartbreaking. Before long, the story got real — very real — and I was hooked. After the credits rolled, my colleagues' reviews came in:
A really beautiful, honest, and engaging film. It shows the many tough challenges of farming with nature rather than against it, but leads with the opportunities and a hopeful optimism.
I don't think I've ever seen such a stunning illustration of the ecology of diversified farming – the challenges, the potential, and all the interconnectedness of a complex farm ecosystem.
More dead chickens! Why did you make me watch this??
Indeed, midway through the film, the casualties start to pile up. John, Molly and their team face a seemingly never-ending string of predator attacks, pest and disease outbreaks, and other deadly natural phenomena as they struggle to make Apricot Lane Farms a sustainable enterprise. Although the relentless mishaps challenge their core belief in working with nature rather than against it, they persist, learning something from each experience and finding creative ways to adapt.
Their story, while unique in many ways, contains some key lessons for U.S. agriculture:
Soil is paramount.
When the Chesters first arrived at Apricot Lane Farms, their newly acquired soil was so compacted and devoid of organic matter, they could hardly break it with a shovel. "The soil is dead," John says flatly. "And we have no idea how to bring it back to life." But with the help of consultant and soil guru Alan York, they set about enriching it. "Plants build soil," Alan said as they seeded cover crops. They also installed a state-of-the-art compost tea system and added animals (so many animals!) for their manure. And indeed, by the end of the film—which spans a seven-year period of historic California drought followed by an unusually wet year—the Chesters' spongier soil seemed to have paid off, as it held water better during dry periods and soaked up more of it when the rains fell. At a time when climate change is driving more weather extremes in every part of the country, building healthy soil will be critical to ensuring that farmers can be successful.
2. Increasing a farm’s biodiversity is critical (and hard).
Someone recently said to me that farmers are the only manufacturers who work outside, completely exposed to the elements. There's truth in that, for sure, but the choice of the word "manufacturers" is revealing. Factories typically make one thing, over and over, day in and day out. And farming in the United States has become a lot like that—an overwhelmingly industrial process, divorced from nature and, in fact, often fighting it tooth and nail. In the film, we see Alan explaining how the Chesters must emulate how natural ecosystems work (we call this agroecology). His mantra: "Diversify, diversify, diversify." John and Molly take this to the extreme, eventually farming 200+ crops and animals across pastures, orchards, and a large vegetable garden. A plethora of wildlife also returns, including new pests that require more creativity and further diversification to combat. Alan promises all this diversity will become simplicity, but as John notes, "a simple way of farming is just not easy."
3. Few farmers can go to the lengths the Chesters have. But most don’t need to.
The 76 varieties of stone fruit trees John and Molly now tend is…probably a bit much for most farmers. And without access to investors like they recruited, few farm startups can afford fancy composting systems, miles of new irrigation line, and the costs associated with repeated trial and error. It is never clear, in the film, how much up-front and continued investment was necessary to do what they did at Apricot Lane Farms (though we can assume it was a lot). Nor do we know at what point in the saga that investment was fully recouped, if it has been. But recent research has shown that even more limited and lower-cost efforts at diversification on farms—for example, expanding from two crops to three or four, or planting prairie strips around the edges of crop fields—can have substantial benefits. And federal farm programs provide help (though not nearly enough) for farmers to do such things.
4. One way or another, the ecological debts of our industrial farming system must be paid.
Apricot Lane Farms required substantial upfront investment not only because the Chesters had ambitious plans, but also because they needed to pay down an enormous ecological debt racked up on that piece of land over the years. Industrial agriculture has been called an "extraction industry" because it takes nutrients from the land without replacing them, allows precious soil to wash or blow away, and sends rainwater running off the surface rather than percolating down to refill underground aquifers for later use. Due to decades of short-sighted management, this is the situation on farmland all across this country. And while John, Molly, and their investors had the means to take on Apricot Lane's ecological debt, it's not fair or realistic to expect farmers to make up for the damage caused by industrial practices and the public policies that have incentivized them. Rather, "The Biggest Little Farm" shows once again why shifting agricultural policies to help farmers diversify the landscape and rebuild their soil and is a smart investment in the future.
5. Nature is breathtakingly beautiful.
The film's message is in line with what the science tells us about farmland diversification and healthy soil, and it comes at a time when legislators in many states and in Congress are looking to expand policy supports and public investments to help more farmers advance soil health. Even though Apricot Lane is just one farm, and a unique one at that, my hope is that this film adds to the conversation. But you don't have to be an advocate for healthy soil policy to appreciate the movie, which above all is visually stunning and brimming with optimism. You'll marvel at the ways John Chester's cinematography captures the beauty and devastation of nature and life on a diversified, ecologically-based farm—from aerial footage of painstakingly designed orchards to images of playful lambs and terrifying wildfires, infrared footage of nocturnal predators, and superslomo shots of the hummingbirds and beneficial insects who return as part of the farm's renewal. If you like that iPhone commercial, you'll find this film equally appealing.
The Biggest Little Farm opens this Friday, May 10, in Los Angeles and New York, and nationwide May 17.
EcoWatch Daily Newsletter
On Monday and Tuesday of the week that President Donald Trump held his first rally since March in Tulsa, Oklahoma, the county reported 76 and 96 new coronavirus cases respectively, according to POLITICO. This week, the county broke its new case record Monday with 261 cases and reported a further 206 cases on Tuesday. Now, Tulsa's top public health official thinks the rally and counterprotest "likely contributed" to the surge.
- No Social Distancing or Mask Requirement at Trump's Mt ... ›
- Trump Plans to End Federal Funding for COVID-19 Testing Sites ... ›
- Attendees at Trump's First Rally Since March Can't Sue if They Get ... ›
Rainforests are an important defense against climate change because they absorb carbon. But many are being destroyed on a massive scale.
- Brazil's Amazon Rainforest Is the Wild West for Illegal Gold Miners ... ›
- Trump Moves to Open 16.7 Million Acre Alaskan Rainforest to ... ›
- Amazon Rainforest Reaches Point of No Return - EcoWatch ›
As we look for advanced technology to replace our dependence on fossil fuels and to rid the oceans of plastic, one solution to the climate crisis might simply be found in rocks. New research found that dispersing rock dust over farmland could suck billions of tons of carbon dioxide from the air every year, according to the first detailed large scale analysis of the technique, as The Guardian reported.
- California Startup Opus 12 Recycles Carbon Dioxide - EcoWatch ›
- UK Biomass Plant Starts Groundbreaking Carbon Capture Project ... ›
- 8 Ways to Sequester Carbon to Avoid Climate Catastrophe - EcoWatch ›
By Tim Radford
German scientists now know why so many fish are so vulnerable to ever-warming oceans. Global heating imposes a harsh cost at the most critical time of all: the moment of spawning.
Nearing the Brink<p>Since <a href="https://climatenewsnetwork.net/abundant-fish-need-cool-seas-and-protection/" target="_blank">fish in the temperate zones already experience a wide variation</a> in seasonal water temperatures, it hasn't been obvious why species such as <a href="https://climatenewsnetwork.net/sardines-swim-into-northern-waters-to-keep-cool/" target="_blank">cod have shifted nearer the Arctic, and sardines have migrated to the North Sea</a>.</p><p>But <a href="https://climatenewsnetwork.net/ocean-warming-spurs-marine-life-to-rapid-migration/" target="_blank">marine creatures are on the move</a>, and although there are other factors at work, including overfishing and <a href="https://climatenewsnetwork.net/fish-cant-smell-well-in-more-acidic-seas/" target="_blank">the increasingly alarming changes in ocean chemistry</a>, thanks to ever-higher levels of dissolved carbon dioxide, temperature change is part of the problem.</p><p>The latest answer, Dr Dahlke and his colleagues report in the journal <a href="https://science.sciencemag.org/cgi/doi/10.1126/science.aaz3658" target="_blank">Science</a>, is that many fish may already be living near the limits of their thermal tolerance.</p><p>The temperature safety margins during the moments of spawning and embryo might be very precise, and over hundreds of thousands of years of evolution, marine and freshwater species have worked out just what is best for the next generation. Rapid global warming upsets this equilibrium.</p>
By Sherry H-Y. Chou, Aarti Sarwal and Neha S. Dangayach
The patient in the case report (let's call him Tom) was 54 and in good health. For two days in May, he felt unwell and was too weak to get out of bed. When his family finally brought him to the hospital, doctors found that he had a fever and signs of a severe infection, or sepsis. He tested positive for SARS-CoV-2, the virus that causes COVID-19 infection. In addition to symptoms of COVID-19, he was also too weak to move his legs.
When a neurologist examined him, Tom was diagnosed with Guillain-Barre Syndrome, an autoimmune disease that causes abnormal sensation and weakness due to delays in sending signals through the nerves. Usually reversible, in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.
We are neurologists specializing in intensive care and leading studies related to neurological complications from COVID-19. Given the occurrence of Guillain-Barre Syndrome in prior pandemics with other corona viruses like SARS and MERS, we are investigating a possible link between Guillain-Barre Syndrome and COVID-19 and tracking published reports to see if there is any link between Guillain-Barre Syndrome and COVID-19.
Some patients may not seek timely medical care for neurological symptoms like prolonged headache, vision loss and new muscle weakness due to fear of getting exposed to virus in the emergency setting. People need to know that medical facilities have taken full precautions to protect patients. Seeking timely medical evaluation for neurological symptoms can help treat many of these diseases.
What Is Guillain-Barre Syndrome?
Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Most commonly, the injury involves the protective sheath, or myelin, that wraps nerves and is essential to nerve function.
Without the myelin sheath, signals that go through a nerve are slowed or lost, which causes the nerve to malfunction.
To diagnose Guillain-Barre Syndrome, neurologists perform a detailed neurological exam. Due to the nerve injury, patients often may have loss of reflexes on examination. Doctors often need to perform a lumbar puncture, otherwise known as spinal tap, to sample spinal fluid and look for signs of inflammation and abnormal antibodies.
Studies have shown that giving patients an infusion of antibodies derived from donated blood or plasma exchange – a process that cleans patients' blood of harmful antibodies - can speed up recovery. A very small subset of patients may need these therapies long-term.
The majority of Guillain-Barre Syndrome patients improve within a few weeks and eventually can make a full recovery. However, some patients with Guillain-Barre Syndrome have lingering symptoms including weakness and abnormal sensations in arms and/or legs; rarely patients may be bedridden or disabled long-term.
Guillain-Barre Syndrome and Pandemics
As the COVID-19 pandemic sweeps across the globe, many neurologic specialists have been on the lookout for potentially serious nervous system complications such as Guillain-Barre Syndrome.
Though Guillain-Barre Syndrome is rare, it is well known to emerge following bacterial infections, such as Campylobacter jejuni, a common cause of food poisoning, and a multitude of viral infections including the flu virus, Zika virus and other coronaviruses.
Studies showed an increase in Guillain-Barre Syndrome cases following the 2009 H1N1 flu pandemic, suggesting a possible connection. The presumed cause for this link is that the body's own immune response to fight the infection turns on itself and attacks the peripheral nerves. This is called an "autoimmune" condition. When a pandemic affects as many people as our current COVID-19 crisis, even a rare complication can become a significant public health problem. That is especially true for one that causes neurological dysfunction where the recovery takes a long time and may be incomplete.
Though there is clear clinical suspicion that COVID-19 can lead to Guillain-Barre Syndrome, many important questions remain. What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection? Does Guillain-Barre Syndrome happen more often in those who have been infected with COVID-19 compared to other types of infections, such as the flu?
The only way to get answers is through a prospective study where doctors perform systematic surveillance and collect data on a large group of patients. There are ongoing large research consortia hard at work to figure out answers to these questions.
Understanding the Association Between COVID-19 and Guillain-Barre Syndrome
While large research studies are underway, overall it appears that Guillain-Barre Syndrome is a rare but serious phenomenon possibly linked to COVID-19. Given that more than 10.7 million cases have been reported for COVID-19, there have been 10 reported cases of COVID-19 patients with Guillain-Barre Syndrome so far – only two reported cases in the U.S., five in Italy, two cases in Iran and one from Wuhan, China.
It is certainly possible that there are other cases that have not been reported. The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients. Also, just because Guillain-Barre Syndrome occurs in a patient diagnosed with COVID-19, that does not imply that it was caused by the virus; this still may be a coincident occurrence. More research is needed to understand how the two events are related.
Due to the pandemic and infection-containment considerations, diagnostic tests, such as a nerve conduction study that used to be routine for patients with suspected Guillain-Barre Syndrome, are more difficult to do. In both U.S. cases, the initial diagnosis and treatment were all based on clinical examination by a neurological experts rather than any tests. Both patients survived but with significant residual weakness at the time these case reports came out, but that is not uncommon for Guillain-Barre Syndrome patients. The road to recovery may sometimes be long, but many patients can make a full recovery with time.
Though the reported cases of Guillain-Barre Syndrome so far all have severe symptoms, this is not uncommon in a pandemic situation where the less sick patients may stay home and not present for medical care for fear of being exposed to the virus. This, plus the limited COVID-19 testing capability across the U.S., may skew our current detection of Guillain-Barre Syndrome cases toward the sicker patients who have to go to a hospital. In general, the majority of Guillain-Barre Syndrome patients do recover, given enough time. We do not yet know whether this is true for COVID-19-related cases at this stage of the pandemic. We and colleagues around the world are working around the clock to find answers to these critical questions.
Sherry H-Y. Chou is an Associate Professor of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh.
Aarti Sarwal is an Associate Professor, Neurology, Wake Forest University.
Neha S. Dangayach is an Assistant Professor of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai.
Disclosure statement: Sherry H-Y. Chou receives funding from The University of Pittsburgh Clinical Translational Science Institute (CTSI), the National Institute of Health, and the University of Pittsburgh School of Medicine Dean's Faculty Advancement Award. Sherry H-Y. Chou is a member of Board of Directors for the Neurocritical Care Society. Neha S. Dangayach receives funding from the Bee Foundation, the Friedman Brain Institute, the Neurocritical Care Society, InCHIP-UConn Center for mHealth and Social Media Seed Grant. She is faculty for emcrit.org and for AiSinai. Aarti Sarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Reposted with permission from The Conversation.
One of the initial reasons social distancing guidelines were put in place was to allow the healthcare system to adapt to a surge in patients since there was a critical shortage of beds, ventilators and personal protective equipment. In fact, masks that were designed for single-use were reused for an entire week in some hospitals.
- Silent Threat of the Coronavirus: America's Dependence on Chinese ... ›
- Rich Countries Are Buying up Medical Supplies, Leaving Poor ... ›
By Jake Johnson
Unity Task Forces formed by presumptive Democratic presidential nominee Joe Biden and Sen. Bernie Sanders unveiled sweeping party platform recommendations Wednesday that—while falling short of progressive ambitions in a number of areas, from climate to healthcare—were applauded as important steps toward a bold and just policy agenda that matches the severity of the moment.
"We've moved the needle a lot, especially on environmental justice and upping Biden's ambition," said Sunrise Movement co-founder and executive director Varshini Prakash, a member of the Biden-Sanders Climate Task Force. "But there's still more work to do to push Democrats to act at the scale of the climate crisis."
The climate panel—co-chaired by Rep. Alexandria Ocasio-Cortez (D-N.Y.) and former Secretary of State John Kerry—recommended that the Democratic Party commit to "eliminating carbon pollution from power plants by 2035," massively expanding investments in clean energy sources, and "achieving net-zero greenhouse gas emissions for all new buildings by 2030."
In a series of tweets Wednesday night, Ocasio-Cortez—the lead sponsor of the House Green New Deal resolution—noted that the Climate Task Force "shaved 15 years off Biden's previous target for 100% clean energy."
"Of course, like in any collaborative effort, there are areas of negotiation and compromise," said the New York Democrat. "But I do believe that the Climate Task Force effort meaningfully and substantively improved Biden's positions."
Today the 6 Biden-Sanders Unity Task Forces are unveiling final language. The Climate Task Force accomplished a gr… https://t.co/gz3broq2qe— Alexandria Ocasio-Cortez (@Alexandria Ocasio-Cortez)1594240617.0
The 110 pages of policy recommendations from the six eight-person Unity Task Forces on education, the economy, criminal justice, immigration, climate change, and healthcare are aimed at shaping negotiations over the 2020 Democratic platform at the party's convention next month.
Sanders said that while the "end result isn't what I or my supporters would've written alone, the task forces have created a good policy blueprint that will move this country in a much-needed progressive direction and substantially improve the lives of working families throughout our country."
"I look forward to working with Vice President Biden to help him win this campaign," the Vermont senator added, "and to move this country forward toward economic, racial, social, and environmental justice."
Biden, for his part, applauded the task forces "for helping build a bold, transformative platform for our party and for our country."
"I am deeply grateful to Bernie Sanders for working with us to unite our party and deliver real, lasting change for generations to come," said the former vice president.
On the life-or-death matter of reforming America's dysfunctional private health insurance system—a subject on which Sanders and Biden clashed repeatedly throughout the Democratic primary process—the Unity Task Force affirmed healthcare as "a right" but did not embrace Medicare for All, the signature policy plank of the Vermont senator's presidential bid.
Instead, the panel recommended building on the Affordable Care Act by establishing a public option, investing in community health centers, and lowering prescription drug costs by allowing the federal government to negotiate prices. The task force also endorsed making all Covid-19 testing, treatments, and potential vaccines free and expanding Medicaid for the duration of the pandemic.
"It has always been a crisis that tens of millions of Americans have no or inadequate health insurance—but in a pandemic, it's potentially catastrophic for public health," the task force wrote.
Dr. Abdul El-Sayed, a former Michigan gubernatorial candidate and Sanders-appointed member of the Healthcare Task Force, said that despite major disagreements, the panel "came to recommendations that will yield one of the most progressive Democratic campaign platforms in history—though we have further yet to go."
We rein in #pharma's greed by: 1) Allowing Medicare to FINALLY negotiate Rx drugs FOR ALL AMERICANS 2) Using Rx d… https://t.co/6k9iUCLMp7— Abdul El-Sayed (@Abdul El-Sayed)1594238411.0
Observers and advocacy groups also applauded the Unity Task Forces for recommending the creation of a postal banking system, endorsing a ban on for-profit charter schools, ending the use of private prisons, and imposing a 100-day moratorium on deportations "while conducting a full-scale study on current practices to develop recommendations for transforming enforcement policies and practices at ICE and CBP."
Marisa Franco, director of immigrant rights group Mijente, said in a statement that "going into these task force negotiations, we knew we were going to have to push Biden past his comfort zone, both to reconcile with past offenses and to carve a new path forward."
"That is exactly what we did, unapologetically," said Franco, a member of the Immigration Task Force. "For years, Mijente, along with the broader immigrant rights movement, has fought to reshape the narrative around immigration towards racial justice and to focus these very demands. We expect Biden and the Democratic Party to implement them in their entirety."
"There is no going back," Franco added. "Not an inch, not a step. We must only move forward from here."
Reposted with permission from Common Dreams.
- Poll: 96% of Democratic Voters Want 2020 Nominee to Prioritize ... ›
- House Democrats Hold First Climate Change Hearings in More ... ›
- Latino Voters Worried About Climate Change Could Swing 2020 ... ›